Try it
Pharmacology · Endocrine drugs: antiandrogens
Sample itemA man with metastatic castration-resistant prostate cancer is started on abiraterone with prednisolone. What is the reason for the steroid?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
C. Abiraterone inhibits CYP17, lowering cortisol and increasing mineralocorticoid excess, so steroid replacement is needed
Abiraterone inhibits CYP17A1 in adrenal and tumour tissue, blocking androgen synthesis, and the resulting ACTH rise causes mineralocorticoid excess with hypertension and hypokalaemia unless glucocorticoid is replaced. Flutamide and bicalutamide are androgen receptor antagonists.
Option by option
A. It enhances abiraterone's antiandrogen effect directly
The steroid is not an antiandrogen booster.
B. It treats bone pain only
Pain control is not the main reason.
C. Abiraterone inhibits CYP17, lowering cortisol and increasing mineralocorticoid excess, so steroid replacement is needed (correct)
Correct. Prednisolone replaces cortisol and suppresses ACTH drive.
D. It prevents abiraterone from being metabolised
Prednisolone does not alter abiraterone metabolism.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Pharmacology questions
- Emergency drugsA patient develops stridor, wheeze and hypotension minutes after an injection. What is t…
- AntiepilepticsWhat is the preferred first-line drug for a patient in generalised convulsive status epi…
- AntimicrobialsWhich drug can cause a disulfiram-like reaction when taken with alcohol?
- AntiepilepticsWhich drug is preferred for uncomplicated childhood absence seizures?